Woxxakem 100 Tablet contains Fluvoxamine 100mg, a selective serotonin reuptake inhibitor (SSRI) primarily indicated for the treatment of obsessive-compulsive disorder (OCD) and major depressive disorder (MDD). Fluvoxamine functions by inhibiting the reuptake of serotonin in the central nervous system, thereby increasing serotonin availability and enhancing neurotransmission, which helps alleviate symptoms of depression and anxiety-related conditions. Woxxakem 100 is prescribed to improve mood, reduce obsessive thoughts, and control compulsive behaviors. The medication is typically administered once daily, preferably in the evening, with dosage adjustments based on clinical response and tolerability. Common side effects may include nausea, headache, insomnia, and dizziness, which are generally transient. Caution is advised when prescribing Woxxakem 100 to patients with a history of bipolar disorder, seizures, or hepatic impairment. It is contraindicated in individuals taking monoamine oxidase inhibitors (MAOIs) or with known hypersensitivity to Fluvoxamine. Patients should be monitored for signs of serotonin syndrome, especially when combined with other serotonergic agents. Abrupt discontinuation should be avoided to prevent withdrawal symptoms. Woxxakem 100 should be used under strict medical supervision, with regular follow-up to assess efficacy and safety.